Passive antibody therapy for infectious diseases (Q35889582)

10 August 2017

1 reference

title

Passive antibody therapy for infectious diseases (English)

1 reference

10 August 2017

1 reference

Arturo Casadevall

1 reference

10 August 2017

Liise-anne Pirofski

1 reference

10 August 2017

Ekaterina Dadachova

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Nature Reviews Microbiology

10 August 2017

published in

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

695-703

1 reference

Serum therapy revisited: animal models of infection and development of passive antibody therapy

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Antibody-mediated regulation of cellular immunity and the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Prevention of respiratory syncytial virus infection in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Vaccines for the prevention of diseases caused by potential bioweapons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Immunotherapy: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of Cryptococcus neoformans infection in murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Feasibility of radioimmunotherapy of experimental pneumococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

More is not necessarily better: prozone-like effects in passive immunization with IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Chronic ECHO type 5 virus meningoencephalitis in X-linked hypogammaglobulinemia: Treatment with immune plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Clinical use of human globulin immune to rabies virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Historic aspects of intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Continuous cultures of fused cells secreting antibody of predefined specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Serologic therapy of tetanus in the United States, 1965-1971.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Equine antitoxin use and other factors that predict outcome in type A foodborne botulism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Serum therapy for Cryptococcal meningitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

Use of Convalescent Measles Serum to Control Measles in a Preparatory School

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

inferred from DOI database lookup

7 January 2021

based on heuristic

Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO974

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRMICRO974

1 reference

10 August 2017

1 reference